The following is a summary of the Cutera, Inc (CUTR) Q2 2024 Earnings Call Transcript:

Financial Performance:

• Q2 2024 revenue was $34.4 million, down from $61.8 million in Q2 2023, a 44% decrease year-over-year.

• Non-GAAP gross profit for Q2 2024 was $9.6 million, with a gross margin rate of 28.8%.

• Non-GAAP loss from operations for Q2 2024 was $21.3 million.

• Cutera provided revised full-year revenue guidance to $140 million to $145 million from a prior range of $160 million to $170 million.

Business Progress:

• International launch of AviClear was successful, with over 70 systems sold outside of North America.

• New capital sales organization structure implemented in North America.

• Partnership established with L'Oreal's SkinCeuticals business in Japan, expected to launch in Q4 2024.

Opportunities:

• The international success of AviClear and restructuring in North America present opportunities for growth and improved sales productivity.

• The new partnership with L'Oreal's SkinCeuticals in Japan represents potential growth in skincare.

Risks:

• Continued macroeconomic pressures affecting capital equipment revenue, particularly in North America.

• High sales force turnover in North America impacting short-term revenue.

More details: Cutera IR

Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.